Pipeline

THERAPEUTIC AREA COMPOUND NAME DOSAGE FORM INDICATION PHASE (US/EU) Collaboration (US/EU) PHASE (EX-US)
Infections Myc-102 cream Dermatomycosis Preclinical in vitro  activity and toxicology studies   CompletedPhase III
Myc-102 capsules Systemicmycosis Preclinical in vitro  activity and toxicology studies   CompletedPhase III
Myc-102 oralrinse Gingivitis
Periodontitis
Preclinical in vitro  activity and toxicology studies   Phase II
Myc-102 pessary Vaginalcandidiasis Preclinical in vitro  activity and toxicology studies   Preclinicalstudy
Myc-102 forinhalationuse Fungalpneumonia Preclinical in vitro  activity and toxicology studies   Preclinicalstudy
Mul-1867 inhalation Cysticfibrosis Preclinical in vitro  activity and toxicology studies   Compassionatehumanstudies
Mul-1867 spray Burn wound infections
Diabetic ulcers
Trophic ulcers
Soft-tissue infections
Preclinical in vitro  activity and toxicology studies Proof-of-concept animal studies
Mul-1867 eyedrops Conjunctivitis Preclinical in vitro  activity and toxicology studies Proof-of-concept animal studies
MV-4 antisepticsolutions Preclinical in vitro  activity and toxicology studies   RegisteredasSanitizer
Teg-379 cream Herpessimplexvírusinfection Preclinical in vitro  activity and toxicology studies  
Phase II
Teg-379 capsules Herpessimplexvírusinfection Preclinical in vitro  activity and toxicology studies   Preclinicalstudy
Imm-28 pessaries Vaginitis/Colpitis Feasibility study   CompletedPhase III
AST-1753 capsules MRSA infection Proof-of-concept animal studies   CompletedPhase III
T-169 capsules HIV-1, HIV-2 Proof-of-concept animal studies   Preclinicalstudy
Liver diseases Hep-1732 capsules Chronic hepatitis C virus (HCV) genotype 1
Exacerbations of chronic hepatitis C virus (HCV) Cirrhosis
Feasibility study Phase II
Hep-114 capsules Toxic live damage, Drug-induced liver injury Feasibility study Completed Phase III
Hep-114 intravenous Toxic live damage, Drug-induced liver injury Feasibility study Phase III
Cancer RecD1 intravenous Pancreaticcancer Preclinical in vitro  activity and toxicology studies   Feasibilitystudy
Autoimmune RecD1 intravenous GraftVersusHostDisease Preclinical in vitro  activity and toxicology studies   Feasibilitystudy